Tech Mahindra : Selected As Terumo BCT’s Global Innovation And Development Partner

To set up a dedicated ODC in Bangalore to help Terumo BCT in product development,
re-engineering & digital automation

Bangalore, 09 October 2017: Tech Mahindra, a specialist in digital transformation, consulting and business re-engineering, today announced becoming one of the global Innovation and Development (I&D) partners of Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies. This extends Tech Mahindra's existing relationship with Terumo BCT.

Terumo BCT is headquartered in Lakewood, Colorado and serves customers across 130 countries. As a leading global medical device company and a world leader in blood processing system, Terumo BCT offers a unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading innovations in therapeutic apheresis and cellular processing.

This initiative with Tech Mahindra is designed to complement and extend Terumo BCT's global development capabilities with a particular focus on the India market. Tech Mahindra will provide Medical Device Engineering services spanning Value Engineering, Regulatory Compliance, New Product Development, Digital Technologies, and Sustenance out of a dedicated Offshore Development Centre (ODC) at the company's Bangalore campus.

'We are delighted to launch this initiative with Terumo BCT. This is a testament to Tech Mahindra's industry leading expertise in Engineering, Compliance, and the Internet of Things for the Medical Devices segment. We share Terumo BCT's drive to improve efficiency and patient outcomes leveraging Tech Mahindra's proven capabilities in new product development including software development/testing, regulatory documentation and digital areas like Agile, AI, automation and analytics,' said Karthikeyan Natarajan, SVP & Global Head Engineering, Tech Mahindra.

'I am confident that this relationship will benefit their engineering efforts and goal to launch products into the global marketplace in the fastest possible time.'

'We collaborate with our customers to improve patient and clinical outcomes through the latest innovations,' said Palani Palaniappan, executive VP of I&D, Terumo BCT. 'Tech Mahindra is an important part of our effort to bring advancements to our customers even faster.'

About Terumo BCT

Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.

Connect with us on www.techmahindra.com || Our Social Media Channels

For Further Queries:

Terumo BCT Media Contact

Bradley Hein, Terumo BCT Sr. Manager Integrated Communications | Phone: [phone] | E-mail: [e-mail]

Tech Mahindra Media Contact

Shalini Singh | Global Media Relations & PR |Tech Mahindra |E-mail: [e-mail]

Disclaimer

Certain statements in this release concerning the future prospects of Tech Mahindra Limited ('the Company' or 'TechM') are forward-looking statements. These statements by their nature involve risks and uncertainties that could cause Company's actual results differ materially from such forward looking statements. The Company, from time to time, makes written and oral forward-looking statements based on information available with the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.